Embecta (Nasdaq:EMBC) announced a new publication introducing best practices for insulin injection techniques and education.
("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced a new landmark publication in the Mayo Clinic Proceedings. The publication ...
After adding nearly 30% in the previous session following its better-than-expected Q4 results for FY24, Embecta (NASDAQ:EMBC) ...
Kurdikar outlined plans to leverage Embecta's commercial channel in ... raised questions about residual value from the discontinued insulin patch pump program. Kurdikar stated that while no ...
PARSIPPANY, N.J., April 01, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. ("embecta") (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, today announced a new landmark ...
systems and insulin pumps, is making blood sugar management more efficient. Strategic initiatives by leading companies are further fueling market expansion. On May 12, 2023, Embecta Corp.